KYTX Kyverna Therapeutics, Inc. logo

KYTX Kyverna Therapeutics, Inc.

Healthcare
$8.61-0.69%ClosedMarket Cap: $377.0M

As of 2026-05-26

Insider Statistics (Q2 2026)

Acquisitions

2

Dispositions

0

Buy/Sell Ratio

0.00

Net Shares

+625,000

Shares Acquired

625,000

Shares Disposed

0

Total Bought ($)

$0.00

Total Sold ($)

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Wed May 20Martini Gregory S.officer: Chief Financial OfficerSell325,000$8.54325,000
Wed May 20Martini Gregory S.Sell0$0.000
Wed May 06Dac Nadiaofficer: Chief Commercial OfficerSell300,000$9.00300,000
Wed May 06Dac NadiaSell0$0.000
Tue Mar 17GRASSO MARCofficer: Chief Financial OfficerSell65,000$8.9565,000
Tue Mar 17GRASSO MARCofficer: Chief Financial OfficerSell10,000$0.0010,000
Tue Mar 17GEHCHAN NAJIofficer: See RemarksSell105,000$8.95105,000
Tue Mar 17GEHCHAN NAJIofficer: See RemarksSell18,000$0.0018,000
Tue Mar 17Biddle Warner Westondirector, officer: Chief Executive OfficerSell350,000$8.95350,000
Tue Mar 17Biddle Warner Westondirector, officer: Chief Executive OfficerSell58,000$0.0058,000
Wed Mar 04Miller Andrew CraigdirectorSell42,945$7.9542,945
Wed Mar 04Miller Andrew CraigdirectorSell11,006$0.0011,006
Wed Mar 04Miller Andrew CraigSell0$0.000
Thu Feb 26Emany Sravan KumardirectorSell42,945$7.9542,945